Lates News

Plus Therapeutics (PSTV.US): The Q1 2025 financial report achieved revenue of $1.059 million, down from $1.677 million, and below the expected value of $1.11 million; earnings per share were -$1.19, worse than the previous value of -$0.75, and below the expected value of -$0.34.